4//SEC Filing
Vo Patrick 4
Accession 0001213900-18-007275
CIK 0001611277other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:01 PM ET
Size
10.6 KB
Accession
0001213900-18-007275
Insider Transaction Report
Form 4
Helix TCS, Inc.HLIX
Vo Patrick
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-01+1,430,306→ 1,430,306 totalExercise: $0.79Exp: 2025-10-31→ Common Stock (1,430,306 underlying) - Award
Stock Option (Right to Buy)
2018-06-01+854,364→ 854,364 totalExercise: $0.11Exp: 2025-02-28→ Common Stock (854,364 underlying) - Award
Common Stock
2018-06-01+1,395,785→ 1,395,785 total
Footnotes (3)
- [F1]Received in exchange for 142,971 shares of Bio-Tech Medical Software, Inc. (?BioTrackTHC?) stock in connection with its merger into Helix Acquisition Sub, Inc., a wholly-owned subsidiary of the Issuer (the ?Merger?). Of the 1,395,785 shares issued to the Reporting Person in connection with the Merger, 75,246 shares are currently being held in escrow and are subject to forfeiture during the eighteen-month period following the Merger to satisfy indemnification obligations of the Issuer, if any.
- [F2]Received in the Merger in exchange for an employee stock option to acquire 87,513 shares of BioTrackTHC common stock for $1.00 per share. The stock option is fully vested.
- [F3]Received in the Merger in exchange for an employee stock option to acquire 146,507 shares of BioTrackTHC common stock for $7.67 per share. The stock option vested 25% on the first anniversary of the date of grant and the remaining 75% of the shares subject to the stock option shall vest 6.25% in quarterly installments, subject to the Reporting Person?s continued employment with BioTrackTHC.
Documents
Issuer
Helix TCS, Inc.
CIK 0001611277
Entity typeother
Related Parties
1- filerCIK 0001742475
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 6:01 PM ET
- Size
- 10.6 KB